In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel
- 5 May 2005
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 104 (1), 181-191
- https://doi.org/10.1016/j.jconrel.2005.02.008
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hybrid films from blends of chitosan and egg phosphatidylcholine for localized delivery of paclitaxelJournal of Pharmaceutical Sciences, 2005
- Poly(sebacic acid‐co‐ricinoleic acid) biodegradable carrier for paclitaxel: In vitro release and in vivo toxicityJournal of Biomedical Materials Research Part A, 2004
- Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trialThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Relapsed Ovarian Cancer: Challenges and Management Strategies for a Chronic DiseaseThe Oncologist, 2002
- In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devicesJournal of Biomedical Materials Research, 2002
- Chitosan‐alginate PEC membrane as a wound dressing: Assessment of incisional wound healingJournal of Biomedical Materials Research, 2002
- Chitosan Induces Apoptosis via Caspase‐3 Activation in Bladder Tumor CellsJapanese Journal of Cancer Research, 2001
- Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymersBiomaterials, 1996
- PaclitaxelDrugs, 1994